Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results
Baerlocher, Gabriela M., Leibundgut, Elisabeth Oppliger, Ayran, Christina, Blaney, Martha, Burington, Bart, Morfeld, Dianne, Odenike, Olatoyosi, Ottman, Oliver, Reddy, Anita, Roeth, Alexander, Spitzer, Gary, Stuart, Monic J., Verstovsek, Srdan, Snyder, David S.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article